Angiogenesis in Acute and Chronic Leukemias

References

• Carmeliet P, Jain R K. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–257
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995; 1: 27–31
   PubMed Web of Science ®Google Scholar
• Yancopoulos G D, Davis S, Gale N W, Rudge J S, Wiegand S J, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–248
   PubMed Web of Science ®Google Scholar
• Iruela-Arispe M, Dvorak H. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemostasis 1997; 78: 672–677
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor Angiogenesis. Cancer Medicine, JR Holland, E Frei, R Bast, D Kufe, D Morton, R Weichselbaum. Williams and Wilkins, Baltimore 1996; 181–204
   Google Scholar
• Weidner N, Carroll P R, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology 1993; 143: 401–409
   PubMed Web of Science ®Google Scholar
• Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred E N, Moore D H, Meli S, Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early breast carcinoma. Journal of the National Cancer Institute 1992; 84: 1875–87
   PubMed Web of Science ®Google Scholar
• Bochner B H, Cote R J, Weidner N, Groshen S, Chen S C, Skinner D G, Nichols P W. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. Journal of the National Cancer Institute 1995; 87: 1603–1612
   PubMed Web of Science ®Google Scholar
• Graham C H, Rivers J, Kerbel R S, Stankiewicz K S, White W L. Extent of vascularization as a prognostic indicator in thin (0.76 mm) malignant melanoma. American Journal of Pathology 1994; 145: 510–514
   PubMed Web of Science ®Google Scholar
• Duly S A, Jagger C J. Bone marrow stromal cell changes in haematological malignancies. Journal of Clinical Pathology 1990; 45: 942–946
   Web of Science ®Google Scholar
• Perez-Atayde A R, Sallan S E, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of Tumor Angiogenesis in the Bone Marrow of Children with Acute Lymphoblastic Leukemia. American Journal of Pathology 1997; 150: 815–821
   PubMed Web of Science ®Google Scholar
• Hussong J W, Rodgers G M, Shami P J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309–313
   PubMed Web of Science ®Google Scholar
• Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J, Büchner T, Berdel W E, Mesters R M. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637–2645
   PubMed Web of Science ®Google Scholar
• Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z, O'Brien S, Keating M, Freireich E, Albitar M. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–2245
   PubMed Web of Science ®Google Scholar
• Kini A R, Kay N E, Peterson L C. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414–1418
   PubMed Web of Science ®Google Scholar
• Fiedler W, Graeven U, Ergun S, Verago S, Kilic N Stockschläder, Hossfeld K D. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870–1875
   PubMed Web of Science ®Google Scholar
• Chen H, Treweeke A T, West D C, Till K J, Cawley J C, Zuzel M, Toh C H. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood 2000; 96: 3181–3187
   PubMed Web of Science ®Google Scholar
• Bellamy W T, Richter L, Frutiger Y, Grogan T M. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Research 1999; 59: 728–733
   PubMed Web of Science ®Google Scholar
• Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoetic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Research 1995; 55: 5687–5692
   PubMed Web of Science ®Google Scholar
• Katoh O, Takahashi T, Oguri T, Kuramoto K, Mihara K, Kobayashi M, Hirata S, Watanabe H. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Research 1998; 23: 5565–5569
   Google Scholar
• Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadbum A, Hyjek E, Gill M, Hicklin D J, Witte L, Moore M AS, Rafii S. Autocrine stimulation VEGFR-2 activates human leukemic cell growth and migration. Journal of Clinical Investigation 2000; 106: 511–521
   PubMed Web of Science ®Google Scholar
• Aguayo A, Estey E., Kantarjian H, Mansouri T, Gidel C, Keating M, Giles F, Estrov Z, Barlogie B, Albitar M. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999; 11: 3717–3721
   Google Scholar
• Molica S, Vrtelli G, Levato D, Gandolfo G M, Liso V. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. British Journal of Haematology 1999; 107: 605–610
   PubMed Web of Science ®Google Scholar
• Aguayo A, O'Brien S, Keating M, Manshouri T, Gidel C, Barlogie B, Beran M, Koller C, Kantarjian H, Albitar M. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia. Blood 2000; 96: 768–770
   PubMed Web of Science ®Google Scholar